Pricing pressures, outpatient migration, supply chain resilience, GLP-1 therapies, and platform-based competition are redefining the medical technology sector worldwide.

Explore the key medtech trends to watch in 2026, from China's procurement reforms and ASC migration to supply chain resilience, GLP-1 therapies, and platform-based competition.

An analysis of Deloitte's Tech Trends 2026 and its strategic implications for international business, investment, and governance.

An analysis of the 2026 Wasabi Global Cloud Storage Index and its implications for international business, digital infrastructure investment, and data sovereignty policies.

An evidence-based analysis of key business trends shaping the global economy in 2026, from generative AI to sustainability, and their implications for governments, investors, and multinational enterprises.

Explore the key business trends shaping 2026, from generative AI and sustainability to workforce transformation and global market shifts. Strategic analysis for leaders, policymakers, and investors.

An analysis of five medtech trends for 2026—China pricing reforms, outpatient migration, supply chain resilience, GLP-1 impact, and platform innovation—and their strategic implications for global healthcare, business, and policy.

Explore the 16 business trends set to define 2026, from AI and e-commerce to sustainability and skills-based hiring, with a focus on their global economic impact.

An analysis of how global futurist thinking and strategic foresight are influencing international business, policy, and governance, and why leaders need to adopt long-term perspectives.

Medical technology enters a period of accelerated change as China's procurement reforms, outpatient migration, supply chain pressures, GLP-1 therapies, and platform-based competition redefine global healthcare markets.

An analysis of five key medtech trends in 2026, from China's volume-based procurement to GLP-1 therapies and platform-based competition, and their international economic and strategic consequences.

An analysis of five structural forces transforming the medtech industry: China's VBP expansion, outpatient migration, supply chain reconfiguration, GLP-1 drug impact, and platform-based competition.